New iSoft CEO aims for $30m cost savings to help turn company around
This article was originally published in Clinica
More job cuts and rationalisation are on the way at iSOFT as its newly appointed CEO starts implementing the necessary measures to pull the beleaguered healthcare IT firm out of the financial doldrums.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.